BIODEL INC's ticker is BIOD and the CUSIP is 09064M204. A total of 41 filers reported holding BIODEL INC in Q4 2013. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $55,000 | +1733.3% | 126,790 | +1032.6% | 0.00% | – |
| Q2 2016 | $3,000 | -92.9% | 11,195 | -91.1% | 0.00% | – |
| Q1 2016 | $42,000 | -8.7% | 126,052 | -6.9% | 0.00% | – |
| Q4 2015 | $46,000 | +31.4% | 135,390 | +69.4% | 0.00% | – |
| Q3 2015 | $35,000 | -58.8% | 79,929 | -2.6% | 0.00% | – |
| Q2 2015 | $85,000 | -1.2% | 82,041 | +13.7% | 0.00% | – |
| Q1 2015 | $86,000 | +22.9% | 72,157 | +36.3% | 0.00% | – |
| Q4 2014 | $70,000 | -14.6% | 52,953 | +7.7% | 0.00% | – |
| Q3 2014 | $82,000 | -28.1% | 49,173 | -6.8% | 0.00% | – |
| Q2 2014 | $114,000 | -18.6% | 52,743 | +2.9% | 0.00% | – |
| Q1 2014 | $140,000 | +35.9% | 51,239 | +13.8% | 0.00% | – |
| Q4 2013 | $103,000 | -24.3% | 45,035 | +4.4% | 0.00% | – |
| Q3 2013 | $136,000 | -18.1% | 43,155 | +8.5% | 0.00% | – |
| Q2 2013 | $166,000 | – | 39,771 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST NEW YORK SECURITIES LLC /NY | 271,234 | $452,961,000 | 0.32% |
| Broadfin Capital, LLC | 1,330,034 | $2,221,000 | 0.23% |
| FNY Managed Accounts LLC | 32,000 | $53,440,000 | 0.16% |
| SABBY MANAGEMENT, LLC | 1,492,803 | $2,493,000 | 0.10% |
| Rotella Capital Management, Inc. | 29,224 | $49,000 | 0.05% |
| SHEPHERD KAPLAN KROCHUK, LLC | 65,225 | $109,000 | 0.01% |
| Orbimed Advisors | 209,700 | $350,000 | 0.00% |
| First Allied Advisory Services, Inc. | 20,000 | $33,000 | 0.00% |
| TFS CAPITAL LLC | 14,017 | $23,000 | 0.00% |
| Plante Moran Financial Advisors, LLC | 1,470 | $2,000 | 0.00% |